Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats.
D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects*; D001862:Bone Resorption; D002352:Carrier Proteins / Q000032:analysis / Q000235:genetics / Q000502:physiology; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D006023:Glycoproteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D008562:Membrane Glycoproteins / Q000032:analysis / Q000235:genetics / Q000502:physiology; D009569:Nitric Oxide / Q000032:analysis; D020030:Nitric Oxide Donors / Q000494:pharmacology*; D009603:Nitroso Compounds / Q000494:pharmacology; D010010:Osteoclasts / Q000502:physiology*; D053244:Osteoprotegerin; D010052:Ovariectomy; D053245:RANK Ligand; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D018160:Receptors, Cytoplasmic and Nuclear / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor; D020133:Reverse Transcriptase Polymerase Chain Reaction; D017154:Stromal Cells / Q000166:cytology / Q000187:drug effects
D002352:Carrier Proteins; D006023:Glycoproteins; D008562:Membrane Glycoproteins; C093285:NOC 18; D020030:Nitric Oxide Donors; D009603:Nitroso Compounds; D053244:Osteoprotegerin; D053245:RANK Ligand; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506032:Tnfrsf11b protein, rat; D009569:Nitric Oxide; D016173:Macrophage Colony-Stimulating Factor